FDA Inspection 1155762 — Xinxiang Tuoxin Pharmaceutical Co. Ltd
The FDA completed an inspection of Xinxiang Tuoxin Pharmaceutical Co. Ltd on Oct 22, 2021 in Xinxiang. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Oct 22, 2021
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Xinxiang (China)